CVMG-01

N/A

Report date: 2022/11/25 17:24:15

Base Information

Drug NameCVMG-01
Drug Alias NameCuraVac MGMyasterixMyasthenia gravis vaccine (CuraVac)Myasterix projectCV-MG-01 +[7] 
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMyasthenia Gravis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCuravac Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCuravac Inc
Active IndicationsN/A
Inactive IndicationsMyasthenia Gravis

Other Information

ATC CodeN/A
Related LinksN/A